Market Overview:
The global lithium medication market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of bipolar disorder and other mental disorders, rising demand for lithium-based medications from emerging economies, and growing focus on research and development activities for new lithium-based medications. The global lithium medication market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into tablets, capsules, oral solution, and others (powders/granules/crystals). On the basis of application, it is divided into hospital pharmacies & clinics; retail pharmacies; mail order pharmacies; long term care facilities; psychiatric hospitals & wards; prisons & juvenile detention centers; military installations or veterans affairs medical centers ; universities or other academic institutions ; research laboratories ; others (including home health care settings).
Product Definition:
Lithium is a medication used to treat bipolar disorder. It may also be used to prevent or delay episodes of mania. Lithium can help reduce the symptoms of bipolar disorder such as mood swings, racing thoughts, and irritability.
Tablets:
Tablets are small solid or semi-solid dosage forms for the delivery of drugs. They can be consumed orally, may be divided into smaller doses if required and are easy to swallow. Tablets have a longer shelf life as compared to other oral dosage forms such as liquids and creams.
Capsules:
Capsules are small containers made up of gelatin, aluminum, and other materials. They protect the medication from sunlight and physical damage. Capsules can be used with liquids or solids and help in ensuring the safety of drugs by avoiding direct contact with the drug substance.
Application Insights:
Based on application, the market is segmented into hospital, clinic and others. The hospital segment dominated the overall market in terms of revenue in 2017. Lithium carbonate and lithium citrate are most commonly used for treating bipolar disorder as well as other conditions such as mania or hypomania. Lithium is also used to treat depression when medical treatment alone has not been effective at restoring a patient's mental health.
The use of lithium medication in treating depression has increased significantly over the past few years owing to its effectiveness at relieving symptoms associated with this condition including suicidal thoughts and feelings of hopelessness along with improving mood stability over a longer period of time compared to other treatments such as ECT (Electroconvulsive Therapy).
Regional Analysis:
Asia Pacific dominated the global market in 2017. The region is expected to maintain its position during the forecast period owing to increasing lithium production and consumption coupled with growing awareness about mental health treatment. Lithium carbonate, which is widely used for treating bipolar disorder, was first produced in Australia by Medmont International Limited in 1990s. However, due to a lack of awareness and availability of effective treatment alternatives, the country’s lithium medication sales were low as compared to other countries until recently. In 2016, after approval from FDA for treating bipolar depression with tablets form only (lithobid), sales increased significantly in this country as well as other South East Asian nations such as Singapore and Malaysia where generic version of brand name product was available at cheaper rates than branded product sold locally.
In addition rising number of patients seeking medical help for mental disorders due to stress caused by hectic work life style has led Lithium meds manufacturers worldwide including GDF Suez Energy Africa Ltd.
Growth Factors:
- Increasing demand for lithium medications from the psychiatric and neurology sectors
- Growing awareness about the benefits of lithium medications among doctors and patients
- Rising prevalence of mental disorders such as bipolar disorder, depression, and anxiety disorders
- Availability of a wide range of lithium medications in different dosage forms and strengths
- Launch of new products by leading players to cater to the needs of various patient segments
Scope Of The Report
Report Attributes
Report Details
Report Title
Lithium Medication Market Research Report
By Type
Tablets, Capsules, Oral Solution
By Application
Hospital, Clinic, Others
By Companies
Bristol-Myers Squibb, Intellipharmaceutics, Pfizer, Eli Lilly, Astrazeneca, GlaxoSmithKline, Lundbeck, Allergan, Otsuka Pharmaceutical, Takeda, NHU Group, Shionogi, APOTEX, Kanghong Pharma, HUAHAI
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
230
Number of Tables & Figures
161
Customization Available
Yes, the report can be customized as per your need.
Global Lithium Medication Market Report Segments:
The global Lithium Medication market is segmented on the basis of:
Types
Tablets, Capsules, Oral Solution
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Clinic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bristol-Myers Squibb
- Intellipharmaceutics
- Pfizer
- Eli Lilly
- Astrazeneca
- GlaxoSmithKline
- Lundbeck
- Allergan
- Otsuka Pharmaceutical
- Takeda
- NHU Group
- Shionogi
- APOTEX
- Kanghong Pharma
- HUAHAI
Highlights of The Lithium Medication Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Tablets
- Capsules
- Oral Solution
- By Application:
- Hospital
- Clinic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Lithium Medication Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Lithium is a medication used to treat bipolar disorder. It helps to regulate moods by stabilizing the levels of neurotransmitters in the brain.
Some of the key players operating in the lithium medication market are Bristol-Myers Squibb, Intellipharmaceutics, Pfizer, Eli Lilly, Astrazeneca, GlaxoSmithKline, Lundbeck, Allergan, Otsuka Pharmaceutical, Takeda, NHU Group, Shionogi, APOTEX, Kanghong Pharma, HUAHAI.
The lithium medication market is expected to grow at a compound annual growth rate of 6.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Lithium Medication Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Lithium Medication Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Lithium Medication Market - Supply Chain
4.5. Global Lithium Medication Market Forecast
4.5.1. Lithium Medication Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Lithium Medication Market Size (000 Units) and Y-o-Y Growth
4.5.3. Lithium Medication Market Absolute $ Opportunity
5. Global Lithium Medication Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Lithium Medication Market Size and Volume Forecast by Type
5.3.1. Tablets
5.3.2. Capsules
5.3.3. Oral Solution
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Lithium Medication Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Lithium Medication Market Size and Volume Forecast by Application
6.3.1. Hospital
6.3.2. Clinic
6.3.3. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Lithium Medication Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Lithium Medication Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Lithium Medication Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Lithium Medication Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Lithium Medication Demand Share Forecast, 2019-2026
9. North America Lithium Medication Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Lithium Medication Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Lithium Medication Market Size and Volume Forecast by Application
9.4.1. Hospital
9.4.2. Clinic
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Lithium Medication Market Size and Volume Forecast by Type
9.7.1. Tablets
9.7.2. Capsules
9.7.3. Oral Solution
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Lithium Medication Demand Share Forecast, 2019-2026
10. Latin America Lithium Medication Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Lithium Medication Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Lithium Medication Market Size and Volume Forecast by Application
10.4.1. Hospital
10.4.2. Clinic
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Lithium Medication Market Size and Volume Forecast by Type
10.7.1. Tablets
10.7.2. Capsules
10.7.3. Oral Solution
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Lithium Medication Demand Share Forecast, 2019-2026
11. Europe Lithium Medication Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Lithium Medication Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Lithium Medication Market Size and Volume Forecast by Application
11.4.1. Hospital
11.4.2. Clinic
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Lithium Medication Market Size and Volume Forecast by Type
11.7.1. Tablets
11.7.2. Capsules
11.7.3. Oral Solution
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Lithium Medication Demand Share, 2019-2026
12. Asia Pacific Lithium Medication Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Lithium Medication Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Lithium Medication Market Size and Volume Forecast by Application
12.4.1. Hospital
12.4.2. Clinic
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Lithium Medication Market Size and Volume Forecast by Type
12.7.1. Tablets
12.7.2. Capsules
12.7.3. Oral Solution
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Lithium Medication Demand Share, 2019-2026
13. Middle East & Africa Lithium Medication Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Lithium Medication Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Lithium Medication Market Size and Volume Forecast by Application
13.4.1. Hospital
13.4.2. Clinic
13.4.3. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Lithium Medication Market Size and Volume Forecast by Type
13.7.1. Tablets
13.7.2. Capsules
13.7.3. Oral Solution
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Lithium Medication Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Lithium Medication Market: Market Share Analysis
14.2. Lithium Medication Distributors and Customers
14.3. Lithium Medication Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Bristol-Myers Squibb
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Intellipharmaceutics
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Pfizer
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Eli Lilly
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Astrazeneca
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. GlaxoSmithKline
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Lundbeck
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Allergan
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Otsuka Pharmaceutical
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Takeda
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. NHU Group
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Shionogi
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. APOTEX
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Kanghong Pharma
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. HUAHAI
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
